All
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma
The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.
The Benefit of Clinical Trial Enrollment for Patients With Cancer
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Addressing Gaps, Challenges and Disparities in AYA Cancer Care
Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.
Unexpected Challenges 11 Years After Breast Cancer
Eleven years post diagnosis and issues related to breast cancer still frustrate me.
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.
A New Comprehensive Hereditary Cancer Solution Has Been Launched
A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.
NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Raising Awareness of Financial Struggles Faced by AYA Cancer Survivors
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Dive Into March 2025 FDA Approvals Across Cancer Subtypes
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.
What To Know About Having Radiation for Metastatic Prostate Cancer
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.
First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.
Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer
Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.
Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC
Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.
First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.
The Positivity Trap of Follicular Lymphoma and Cancer
As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.
Patient With Head and Neck Cancer Dosed in Trial of APR-1051
A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.
Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial
The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.
Inside the Mind of a Bile Duct Cancer Survivor
I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient mentorship.
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with melanoma.
What Patients With Kidney Cancer Need to Know From ASCO GU
There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.
Research Shines Light on Disparities Across Breast Cancer Care
Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.
FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
Life Goes On, Even With Breast Cancer
I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish others strength in their journeys.
Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis
CURE spoke with Leslie Waltke about the importance of physical therapy during a cancer journey.
FDA Expands Pluvicto Indication in Prostate Cancer Subset
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with androgen receptor inhibitors.
SON-1010 Generates Safe Results in Advanced Sarcoma
A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or liposarcoma (LPS).
Solnerstotug Demonstrates Early Efficacy in PD-L1 Resistant Tumors
Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% disease control rate.
